Skip to main content

Mannkind Corp

MNKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000899460

In the last 90 days, Mannkind Corp insiders filed 0 open-market purchases and 4 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $776.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Mannkind Corp insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
2 insiders, $597.1K in total
Insiders trading
2
Net value
−$597.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Mannkind Corp, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Mannkind Corp
NameTitleLast reported holdingLast filingFilings, past year
Binder Steven B.Director752,309Sep 14, 20266
Prentiss Christopher BChief Financial Officer318,668Jul 17, 20264
Marasco DominicPres, Endocrine Business Unit343,398Jul 17, 20262
Tross Stuart AChief People & Workpl Officer1,058,142Jul 17, 20266
Castagna MichaelChief Executive Officer2,433,779Jul 17, 20269
Singh Sanjay REVP Technical Operations478,966Jul 17, 20264
Thomson DavidEVP Genl Counsel & Secretary797,554Jul 17, 20265
Consiglio Ronald JDirector132,342May 22, 20261
Mundkur ChristineDirector254,493May 22, 20261
Hooper Anthony CDirector236,153May 22, 20262
Friedman Michael ADirector–May 22, 20261
Shannon James SamuelDirector64,635May 22, 20262
Grancio JenniferDirector244,815May 22, 20261
Kay SabrinaDirector265,600May 22, 20261
Ahuja AjayChief Medical Officer318,200Mar 25, 20262
Blank BurkhardEVP Chief Medical Officer460,791Jul 17, 20250
Sabella Lauren MEVP Operations349,841Jul 17, 20250
Kresa KentDirector–May 17, 20240
Kocinsky JosephChief Technology Officer745,233Aug 29, 20220
Galindo AlejandroEVP Endocrine Business Unit576,690Aug 24, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2026 (view filing)8:00 PM ETSep 104 daysBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−33.6K$3.81−$127.9K−4.3%752.3K after10b5-1
Aug 10, 2026 (view filing)8:44 PM ETAug 73 daysBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−39.1K$4.06−$158.5K−4.7%785.9K after10b5-1
Jul 17, 2026 (view filing)9:43 PM ETJul 17Same dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−24.1K$4.05−$97.6K−2.9%797.6K after10b5-1
Jul 17, 2026 (view filing)9:42 PM ETJul 17Same dayBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−52.5K$4.06−$213.1K−6.0%824.9K after10b5-1
May 13, 2026 (view filing)May 121 dayBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−16.9K$3.29−$55.7K−2.1%808.0K after10b5-1
May 13, 2026 (view filing)May 121 dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−3.03K$3.29−$9.98K−0.4%826.3K after10b5-1
Jan 9, 2026 (view filing)Jan 81 dayTross Stuart AChief People & Workpl OfficerSSaleCommon Stock, $0.01 Par Value−47.0K$6.33−$297.5K−4.6%985.0K after10b5-1
Dec 19, 2025 (view filing)Dec 172 daysCastagna MichaelChief Executive OfficerSSaleCommon Stock, $0.01 Par Value−65.8K$6.01−$395.5K−2.6%2.50M after10b5-1
Dec 16, 2025 (view filing)Dec 12-164 daysCastagna MichaelChief Executive OfficerSSaleCommon Stock, $0.01 Par Value−42.1K$6.00−$252.7K−1.7%2.50M after2 lots10b5-1
Dec 4, 2025 (view filing)Dec 22 daysCastagna MichaelChief Executive OfficerSSaleCommon Stock, $0.01 Par Value−107.9K$5.57−$601.1K−4.1%2.50M after10b5-1
Dec 4, 2025 (view filing)Dec 22 daysThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−147.8K$5.57−$823.1K−14.9%841.7K after10b5-1
Nov 14, 2025 (view filing)Nov 14Same daySingh Sanjay REVP Technical OperationsSSaleCommon Stock, $0.01 Par Value−18.8K$5.03−$94.4K−4.0%455.2K after10b5-1
Sep 17, 2025 (view filing)Sep 161 dayTross Stuart AChief People & Workpl OfficerSSaleCommon Stock, $0.01 Par Value−47.0K$5.34−$251.0K−4.4%1.03M after10b5-1
Jul 17, 2025 (view filing)Jul 161 dayBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−75.4K$3.94−$296.9K−8.3%830.5K after10b5-1
Jul 17, 2025 (view filing)Jul 161 dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−7.47K$3.94−$29.4K−0.9%841.7K after10b5-1
Jun 10, 2025 (view filing)Jun 10Same dayBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−64.1K$4.00−$256.3K−6.5%925.3K after10b5-1
May 20, 2025 (view filing)May 20Same dayBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−12.1K$4.40−$53.1K−1.2%989.3K after10b5-1
May 20, 2025 (view filing)May 20Same dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−2.35K$4.41−$10.3K−0.3%879.5K after10b5-1
May 15, 2025 (view filing)May 132 daysThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−32.2K$4.68−$150.6K−4.0%772.4K after10b5-1
May 15, 2025 (view filing)May 132 daysBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−80.1K$4.69−$375.9K−7.4%1.01M after10b5-1
Nov 25, 2024 (view filing)Nov 223 daysBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−67.5K$6.89−$465.3K−5.9%1.08M after10b5-1
Nov 19, 2024 (view filing)Nov 154 daysBinder Steven B.DirectorSSaleCommon Stock, $0.01 Par Value−67.5K$6.76−$456.6K−5.9%1.08M after10b5-1
Nov 8, 2024 (view filing)Nov 62 daysTross Stuart AChief People & Workpl OfficerSSaleCommon Stock, $0.01 Par Value−55.0K$7.34−$403.7K−5.4%967.2K after10b5-1
Sep 4, 2024 (view filing)Sep 31 dayTross Stuart AChief People & Workpl OfficerSSaleCommon Stock, $0.01 Par Value−25.0K$6.26−$156.5K−2.4%1.02M after10b5-1
Aug 30, 2024 (view filing)Aug 30Same dayTross Stuart AChief People & Workpl OfficerSSaleCommon Stock, $0.01 Par Value−80.0K$6.33−$506.1K−7.1%1.05M after2 lots10b5-1
Aug 29, 2024 (view filing)Aug 29Same dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $0.01 Par Value−85.1K$6.30−$536.2K−3.6%2.29M after
Aug 29, 2024 (view filing)Aug 29Same dayBinder Steven B.EVP Special ProjectsSSaleCommon Stock, $0.01 Par Value−5.05K$5.94−$30.0K−0.5%1.08M after10b5-1
Aug 29, 2024 (view filing)Aug 29Same dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−5.55K$5.94−$33.0K−0.7%829.8K after10b5-1
Jul 17, 2024 (view filing)Jul 161 dayBinder Steven B.EVP Special ProjectsSSaleCommon Stock, $0.01 Par Value−2.84K$5.93−$16.8K−0.3%1.10M after10b5-1
Jul 17, 2024 (view filing)Jul 161 dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−3.12K$5.93−$18.5K−0.4%857.9K after10b5-1
May 21, 2024 (view filing)May 21Same dayBinder Steven B.EVP Special ProjectsSSaleCommon Stock, $0.01 Par Value−26.0K$4.66−$120.9K−2.3%1.11M after10b5-1
May 21, 2024 (view filing)May 21Same dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $0.01 Par Value−23.5K$4.66−$109.7K−2.6%873.6K after10b5-1
May 14, 2024 (view filing)May 131 dayBinder Steven B.EVP Special ProjectsSSaleCommon Stock, $.01 Par Value−3.62K$4.31−$15.6K−0.4%846.0K after10b5-1
May 14, 2024 (view filing)May 131 dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $.01 Par Value−3.05K$4.31−$13.1K−0.4%783.4K after10b5-1
Dec 15, 2023 (view filing)Dec 14-151 dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−200.5K$4.00−$801.9K−8.5%2.15M after3 lots
Nov 2, 2023 (view filing)Nov 11 dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.25−$42.5K−0.4%2.35M after
Oct 3, 2023 (view filing)Oct 21 dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.08−$40.8K−0.4%2.36M afterAmended
Sep 5, 2023 (view filing)Sep 14 daysCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.61−$46.1K−0.4%2.44M after
Aug 28, 2023 (view filing)Aug 28Same dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $.01 Par Value−8.10K$4.78−$38.7K−1.0%798.8K after10b5-1
Aug 1, 2023 (view filing)Aug 1Same dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.57−$45.7K−0.4%2.50M after10b5-1
Jul 7, 2023 (view filing)Jul 3-54 daysCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.04−$40.4K−0.4%2.51M afterAmended2 lots10b5-1
Jun 2, 2023 (view filing)Jun 11 dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.53−$45.3K−0.4%2.52M after10b5-1
May 26, 2023 (view filing)May 25-261 dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−150.0K$4.55−$681.8K−5.6%2.53M after2 lots10b5-1
May 24, 2023 (view filing)May 24Same dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $.01 Par Value−95.6K$4.68−$447.3K−11.5%735.3K after
May 24, 2023 (view filing)May 24Same dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−150.0K$4.69−$703.5K−6.0%2.33M after
May 5, 2023 (view filing)May 5Same dayCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.00−$40.0K−0.5%2.02M after10b5-1
Apr 5, 2023 (view filing)Apr 32 daysCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$4.13−$41.3K−0.5%2.03M after
Mar 3, 2023 (view filing)Mar 12 daysCastagna MichaelChief Executive OfficerSSaleCommon Stock, $.01 Par Value−10.0K$5.27−$52.7K−0.5%2.04M after
Aug 29, 2022 (view filing)Aug 29Same dayThomson DavidEVP Genl Counsel & SecretarySSaleCommon Stock, $.01 Par Value−7.00K$3.67−$25.7K−1.0%726.0K after
Aug 23, 2022 (view filing)Aug 221 dayGalindo AlejandroEVP Endocrine Business UnitSSaleCommon Stock, $0.01 Par Value−4.62K$3.85−$17.8K−0.6%777.1K after2 lots